Munafa Stock Market Course + Intraday & FNO calls 
Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Protagonist Therapeutics (PTGX)
Technical Analysis Report for USA stock PTGX Protagonist Therapeutics. Dated: 26 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock PTGX Protagonist Therapeutics then click here. or read Experts views on Protagonist Therapeutics or Forecast & share price targets of Protagonist Therapeutics
Protagonist Therapeutics Opened at 150.36 and Closed at: 151.50, which is 0.6% of previous session's close. It moved within a range of 147.69 and 152.07
The session was a Bullish session with an average volume of 335400, which is -98.12% of previous session's volumes.
- The stock has shown an up move, and its short term trend is also positive and in an uptrend.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
Support for tomorrow is 149.6 and resistance for tomorrow is 153.98
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 148.77, 146.04 resistance for tomorrow's hourly charts is 153.15, 154.8
10 Day SMA for Protagonist Therapeutics (PTGX) is 153.92 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Protagonist Therapeutics (PTGX) is 148.11 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Protagonist Therapeutics (PTGX) is 137.21 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 119.57 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Protagonist Therapeutics is 104.09 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Protagonist Therapeutics is at 148.11 and 200 DMA is at 104.09, while 50 DMA and 100 DMA are at 137.21 and 119.57 respectively
Protagonist Therapeutics (PTGX) moving average of 20 SMA is at 148.11 and 20 EMA is at 148.49
| Date | Closing Price | 20 SMA | 20 EMA |
| 26 Wed Aug | 151.50 | 148.11 | 148.49 |
| 25 Tue Aug | 150.59 | 147.19 | 148.17 |
| 24 Mon Aug | 154.72 | 146.5 | 147.92 |
| 21 Fri Aug | 154.32 | 145.54 | 147.21 |
| 20 Thu Aug | 150.69 | 144.63 | 146.46 |
| 19 Wed Aug | 154.94 | 143.9 | 146.01 |
Protagonist Therapeutics (PTGX) moving average of 50 SMA is at 137.21 and 50 EMA is at 137.43
| Date | Closing Price | 50 SMA | 50 EMA |
| 26 Wed Aug | 151.50 | 137.21 | 137.43 |
| 25 Tue Aug | 150.59 | 136.39 | 136.86 |
| 24 Mon Aug | 154.72 | 135.63 | 136.3 |
| 21 Fri Aug | 154.32 | 134.73 | 135.55 |
| 20 Thu Aug | 150.69 | 133.84 | 134.78 |
| 19 Wed Aug | 154.94 | 132.94 | 134.13 |
Protagonist Therapeutics (PTGX) moving average of 100 SMA is at 119.57 and 100 EMA is at 124.26
| Date | Closing Price | 100 SMA | 100 EMA |
| 26 Wed Aug | 151.50 | 119.57 | 124.26 |
| 25 Tue Aug | 150.59 | 119.1 | 123.71 |
| 24 Mon Aug | 154.72 | 118.62 | 123.17 |
| 21 Fri Aug | 154.32 | 118.11 | 122.53 |
| 20 Thu Aug | 150.69 | 117.6 | 121.89 |
| 19 Wed Aug | 154.94 | 117.15 | 121.31 |
Protagonist Therapeutics (PTGX) moving average of 200 SMA is at 104.09 and 200 EMA is at 107.19
| Date | Closing Price | 200 SMA | 200 EMA |
| 26 Wed Aug | 151.50 | 104.09 | 107.19 |
| 25 Tue Aug | 150.59 | 103.73 | 106.74 |
| 24 Mon Aug | 154.72 | 103.37 | 106.3 |
| 21 Fri Aug | 154.32 | 102.99 | 105.81 |
| 20 Thu Aug | 150.69 | 102.6 | 105.32 |
| 19 Wed Aug | 154.94 | 102.24 | 104.86 |
Protagonist Therapeutics has performed better than Unitedhealth Group in short term. Holding Protagonist Therapeutics could be a better choice for now!
Resmed Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Resmed Inc, about 3.73% more returns!
Protagonist Therapeutics has performed better than Encompass Health in short term. Holding Protagonist Therapeutics could be a better choice for now!
Becton Dickinson has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Becton Dickinson, about 5.69% more returns!
Therapeuticsmd Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Therapeuticsmd Inc, about 3.04% more returns!
Protagonist Therapeutics has performed better than Supernus Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Insulet Corporation in short term. Holding Protagonist Therapeutics could be a better choice for now!
Omeros Corporation has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Omeros Corporation, about 43.44% more returns!
Novocure has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Novocure, about 8.19% more returns!
Protagonist Therapeutics has performed better than Neurocrine Biosciences in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Seres Therapeutics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Krystal Biotech in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Gossamer Bio in short term. Holding Protagonist Therapeutics could be a better choice for now!
Geron Corporation has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Geron Corporation, about 4.9% more returns!
Protagonist Therapeutics has performed better than Cooper Companies in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Biolinerx in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics Technical analysis of indicators
Price action analysis of Protagonist Therapeutics (PTGX) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Protagonist Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Protagonist Therapeutics in short term but the sell signal is initial and weak.
Protagonist Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Protagonist Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Protagonist Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 153.93 and Protagonist Therapeutics PTGX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Protagonist Therapeutics PTGX stock. Volume based technical analysis of Protagonist Therapeutics PTGX stock is negative.
Protagonist Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock PTGX Protagonist Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PTGX Experts View which covers a lot of information including buying and selling signals
PTGX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Protagonist Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
